ArticleMedicine2026
Cardiometabolic index is associated with hypertension among US older adults: An analysis of NHANES 2011-2018.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is the leading cause of mortality and disability-adjusted life years worldwide. Patients with hypertension suffer a higher risk of metabolic syndrome. The cardiometabolic index (CMI) is an innovative metabolic indicator for screening diabetes mellitus, stroke, and renal dysfunction. However, it remains unclear whether there exists an association between CMI and hypertension among older adults. Thus, the purpose of this study is to investigate the association between CMI and hypertension among older adults. This study included 3067 adults aged 60 years and older from the National Health and Nutrition Examination Survey 2011-2018. Multivariate logistic regression analysis and smooth curve fitting were employed to investigate the association between the CMI and hypertension, with subgroup analyses and interaction tests used to assess the stability of this association across different populations. According to the multivariate logistic regression results, participants with the highest CMI had a statistically significant 86% increased risk of hypertension prevalence compared with participants with the lowest CMI (odds ratio = 1.86; 95% confidence interval = 1.43-2.44, P < .0001) in a fully adjusted model. Furthermore, the application of smoothing curve fitting demonstrated a positive correlation between CMI and hypertension, while subgroup analysis revealed no significant interactions between CMI and specific subgroups (P > .05 for all interactions). CMI exhibited a positive correlation with hypertension among older adults, indicating that CMI is expected to become a simple and cost-effective biomarker.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.